UNSPSC 51284045: Tetracycline phosphate

This classification denotes a tetracycline antibiotic with the molecular formula C22H24N2O8.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NZ662XY5PP. The term tetracycline phosphate is a U.S. FDA Green Book designation. Most nations, for tariff and trade purposes, schedule tetracycline phosphate under HS 29413000. As of Q4 2014, TETRACYCLINE PHOSPHATE remains US FDA's Preferred Term for this commodity. SMILES: C[C@@]1(C2CCCC(C2C(=O)C3=C([C@]4([C@@H](C[C@@H]31)[C@@H](C(=C(C4=O)C(=O)N)O)N(C)C)O)O)O)O.OP(=O)(O)O.

UNSPSC 51284045 Tetracycline phosphate is a Commodity code that nominally describes a specific pharmaceutical product, but recent state and local solicitations tagged under this code reflect a much broader procurement pattern: medical supplies, emergency response consumables, pharmaceuticals, and over-the-counter products sourced through competitive bidding, cooperative purchasing vehicles, and request-for-information market surveys. State and local governments are using this code to acquire medical and first aid supplies for fire departments and rescue divisions, generic multi-source pharmaceuticals through cooperative purchasing alliances, and direct-to-manufacturer prescription fulfillment capabilities through state health agencies. The issuing bodies include city purchasing departments (Tampa), county health authorities (Seminole County, Florida), state health commissions (Texas HHS), and multistate cooperative purchasing administrators (Minnesota Department of Administration). This suggests the code is functioning as a catch-all taxonomy entry for pharmaceutical and medical procurement rather than a strict product-level categorization.

Recent opportunities span Florida, Texas, and Minnesota, with cooperative purchasing vehicles extending reach across multiple states including Oregon. Representative solicitations include Seminole County's IFB for naloxone and drug deactivation systems (1,900 units annually, due July 26, 2023), the City of Tampa's sealed-bid procurement for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division (estimated $700,000, due March 13, 2026, with SLBE set-aside and 5 percent bid discount), the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026, serving state and local facilities across multiple jurisdictions), and the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (response deadline April 3, 2026). The code shows consistent activity across municipal, county, and state health procurement, though the mismatch between the code's nominal scope (a specific tetracycline formulation) and the actual work being bought suggests vendors should verify code alignment with issuing bodies before pursuing opportunities.